The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted.Find sources: "RTI Surgical" – news · newspapers · books · scholar · JSTOR (November 2019) (Learn how and when to remove this template message)
RTI Surgical
Company typePrivate
IndustryMedical technology
Founded1998 as Regeneration Technologies, Inc.
HeadquartersAlachua, Florida, United States
ProductsMedical devices
RevenueIncrease $280 million
Websitewww.rtisurgical.com

RTI Surgical is a medical technology company that was founded in 1998 after spinning off from the University of Florida Tissue Bank Alachua, Florida, United States.

RTI began operations as Regeneration Technologies in Alachua, Fla. In February 1998, the University of Florida Tissue Bank transferred its allograft processing operations, related equipment and technologies, distribution arrangements, and research and development activities to Regeneration Technologies. This spin-off from the University of Florida (UF) is one of the most successful UF technology transfers to date.

In 2012, RTI was a defendant in a civil case involving the body snatching activities of Michael Mastromarino[1] and other organizations supplying RTI with human tissue and body parts.[2][3][4] The suit would have investigated how RTI ignored the questionable credentials of the organizations that supplied them body parts and tissue by forging consent documents and "cutting open the corpses and harvesting tissue, bone and organs and replacing those body parts with materials purchased at local hardware stores, such as PVC pipes and rubber gloves."[5] RTI's legal representation argued that the company is "allowed to accept tissue—without any civil liability whatsoever—as long as they do so without actual knowledge of a contrary intent of the donor" but that they are not, in turn, legally required to investigate consent.[5] The civil case was postponed in September 2012 in order to mediate settlements from RTI for the involved plaintiff families.[5]

Pioneer Surgical was acquired in July 2013 by RTI Biologics, and the company was then renamed RTI Surgical.[6]

In 2020, Montagu Private Equity acquired RTI Surgical’s OEM business.[6]

References

  1. ^ Patterson, Randall (6 October 2006). "How Michael Mastromarino Illegally Harvested and Sold Body Parts -- New York Magazine - Nymag". New York Magazine. Retrieved 28 January 2022.
  2. ^ "Body Brokers Leave Trail of Questions, Corruption - ICIJ". 17 July 2012. Retrieved 28 January 2022.
  3. ^ "Matter of Human Tissue Litig". Justia Law. Retrieved 28 January 2022.
  4. ^ Kirby, Tony (10 November 2012). "Profiteering threatens the altruism of tissue donation". The Lancet. 380 (9854): 1635–1636. doi:10.1016/S0140-6736(12)61934-5. PMID 23162823. S2CID 6651149. Retrieved 28 January 2022.
  5. ^ a b c Hudson, Michael (18 September 2012). "Civil Trial Postponed in U.S. Human Tissue Harvesting Scandal - ICIJ". ICIJ. Retrieved 28 January 2022.
  6. ^ a b "Company History". RTI Surgical.

External links


Categories